The Joint Asia Diabetes Evaluation (JADE) Program is a web-based program. From design to implementation - The Joint Asia Diabetes Evaluation (JADE) program. Delivery of integrated diabetes care using logistics and information technology. The Joint Asia Diabetes Evaluation (JADE) program is an innovative care.
AIMS: The Joint Asia Diabetes Evaluation (JADE) Program is the first web-based program incorporating a comprehensive risk engine, care protocols. From Design To Implementation – The Joint Asia Diabetes Evaluation (JADE. Background: The Joint Asia Diabetes Evaluation (JADE) Program is a web-based program. From Hong Kong Diabetes Registry to Joint Asia Diabetes Evaluation Program. Hong Kong's Joint Asia Diabetes Evaluation Program: integrated diabetes care at its. The Asia Diabetes Foundation (ADF). Quality of care in patients with diabetic kidney disease in Asia: The Joint Asia Diabetes Evaluation. The Joint Asia Diabetes Evaluation (JADE) Program is the first web-based program incorporating a comprehensive risk engine. Joint asia diabetes evaluation (JADE) clerical staff at Merck. Location Vietnam Industry Pharmaceuticals. Delivery of integrated diabetes care using logistics and information technology. The Joint Asia Diabetes Evaluation (JADE) program is.
The Joint Asia Diabetes Evaluation (JADE) Program: a web-based program to translate evidence to clinical practice in Type 2 diabetes.
The Burden of Young- onset Diabetes in the Joint. Asia Diabetes Evaluation Program (JADE)The Burden of Young- onset Diabetes in the Joint. Asia Diabetes Evaluation Program (JADE)Roseanne O. Yeung, Yuying Zhang. Juliana Chan on behalf of the JADE Study Group.
Division of Endocrinology, University of Alberta, Canada. ABSTRACTIn contrast to Caucasian populations where the majority of. Type 1 diabetes, Asian. Type 2 diabetes. concordant with the rapid urbanisation and industrialisation.
People with. young- onset Type 2 diabetes are at high risk of complications given the longer. Given the shifting demography, little is known. Type 2 diabetes in this young- onset Asian population. The JADE program is a technologically enhanced diabetes.
JADE is now in. primary and specialty clinics across 1. Malaysia, China. India, Hong Kong, Philippines, South Korea, Vietnam, Singapore, Thailand. Taiwan, and Indonesia. We found that 1 in 5 patients have been diagnosed with Type. These younger patients were more likely. Familiar clustering was seen, with. Type 2 diabetes. Younger patients were less likely to meet guideline- targets.
LDL- cholesterol control, likely due to the. The individual and public health burdens.